MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat

Device tax spurs Hill-Rom to lay off 200 | Wall Street Beat

By

MassDevice.com Wall Street Beat

Hill-Rom Holdings (NYSE:HRC) said it will lay off about 3% of its workforce, or roughly 200 workers, as it maneuvers to confront the medical device tax set to go into effect next year.

"The company is making these changes to help offset pressures from challenging macroeconomic conditions, regulatory and reimbursement pressures, and the new medical device tax," according to a regulatory filing.

Batesville, Ind.-based Hill-Rom also said it’s taking a $10 million to $13 million hit this year on tangible and intangible impairments, meaning a total charge of $19 million to $22 million for 2012.

Hill-Rom joins Stryker (NYSE:SYK) and Zimmer (NYSE:ZMH) in linking layoffs with the med-tech tax, a 2.3% levy on all U.S. sales of medical devices slated to begin next year. Earlier this month, Zimmer said it plans to offset the entire burden posed by the tax in 2013, in part by laying off about 170 workers. Stryker said late last year that it will cut 5% of its workforce due to the tax, and industry lobby AdvaMed has estimated that the levy will cost the med-tech sector about 11% of its jobs.

 AngioDynamics drops $5M on Microsulis
AngioDynamics (NSDQ:ANGO) said it paid $5 million to acquire a 14.3% stake in microwave ablation developer Microsulis Medical Ltd., in return for exclusive overseas distribution rights to the Accu2i pMTA microwave ablation system and an exclusive option to "buy" Microsulis. Read more

 Kips Bay switches NASDAQ markets

The NASDAQ stock exchange granted Kips Bay Medical‘s (NSDQ:KIPS) request to move from its Global Market to the NASDAQ Capital Market "to take advantage of the Capital Market’s lower listing requirements." Read more

 Luna Innovations, Intuitive Surgical extend pact
Luna Innovations NSDQ:LUNA) and Intuitive Surgical (NSDQ:ISRG) extended a development deal through 2012 to integrate Luna’s shape and position sensing technology into Intuitive’s surgery robots. Read more

 Asahi Kasei begins $2B bid for Zoll

Asahi Kasei (TYO:3407) began its $2.2 billion tender offer for Zoll Medical (NSDQ:ZOLL) at $93 per share. Read more

 CRO Cetero files for bankruptcy after FDA probe
Contract research organization Cetero Research filed for bankruptcy after an FDA probe into allegedly falsified data caused the company’s "liquidity position to become severely constrained" and some lenders declared default due to the "apparent violation of applicable health laws and regulations." Read more

 NASDAQ warns NeuroMetrix

NeuroMetrix (NSDQ:NURO) said the NASDAQ stock exchange warned it of a possible de-listing after its stock price moved below the exchange’s $1-per-share minimum price requirement. Read more

 Report: Six players dominate the EMR market

A sextet of major players – Cerner Cerner (NSDQ:CERN), McKesson McKesson (NYSE:MCK), Siemens Siemens (NYSE:SI), GE Healthcare GE (NYSE:GE), Epic and Allscripts (NSDQ:MDRX) – dominates the market for electronic medical records, according to Kalorama Information. Read more

 Intuitive Surgical, GE, Hitachi, Philips win federal contracts

Intuitive Surgical (NSDQ:ISRG), GE (NYSE:GE), Hitachi (NYSE:HIT) and Philips (NYSE:PHG) all won contracts with the U.S. Defense Dept. 

 Funding Roundup

 Analysts’ ups and downs

  • Allergan (NYSE:AGN): Citigroup increases price target from $94 to $110, maintains "buy" rating.
  • Cardiovascular Systems (NSDQ:CSII): Benchmark Co. initiates coverage with "speculative buy" rating, $15 price target.
  • Edwards Lifesciences (NYSE:EW): JP Morgan maintains "neutral" rating; Citi maintains "buy" rating, $84 price target.
  • Insulet (NSDQ:PODD): Piper Jaffray initiates with "neutral" rating, $21 price target.
  • McKesson (NYSE:MCK): Goldman Sachs raises estimates through 2014, maintains "buy" rating.
  • Opko (NYSE:OPK): Ladenburg Thalmann maintains "buy" rating, $8.50 price target.
  • Smith & Nephew (FTSE:SN): Investec downgrades from "buy" to hold, cuts price target from £6.63 to £6.60.
  • St. Jude Medical (NYSE:STJ): Credit Suisse raises price target from $44 to $49, maintains "outperform" rating.
  • Synergetics (NSDQ:SURG): Wunderlich Securities maintains "buy" rating, $8 target price.
  • Tornier (NSDQ:TRNX): Benchmark Co. initiates coverage at "speculative buy", $31 price target.

In case you missed it

RSS From Medical Design & Outsourcing

  • Protolabs reports mixed-bag results for Q2
    Protolabs (NYSE: PRLB) posted second-quarter earnings today that missed the consensus forecast on Wall Street, though the company beat on revenue. The Maple Plain, Minn–based digital manufacturing outsourcer — which serves medtech and a host of other industries — reported profits of $12.9 million, or 47¢ per share, on sales of $123.0 million for the… […]
  • Integer beats The Street in Q2, boosts sales outlook
    Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic. The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended… […]
  • Keep the end in mind when choosing a medtech partner
    There are five general categories of medtech vendor partners. If the end is apparent in the beginning, the correct type of partner will be more apparent. Jim Reed, Minnetronix Medical Stephen Covey gave the business world this mantra in one of his bestsellers: “Start with the end in mind.” Whether they didn’t read the book… […]
  • Orthofix launches Fiberfuse Strip bone graft
    Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S. Lewisville, Texas–based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures. FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with… […]
  • Thermo Fisher Scientific beats The Street in Q2 results
    Thermo Fisher Scientific (NYSE:TMO) today posted second-quarter results that beat the overall consensus on Wall Street. The Waltham, Mass.–based company reported profits of $1.8 billion, or $4.61 per share, on sales of $9.3 billion for the three months ended July 1, 2021, for a bottom-line gain of 58.1% on sales growth of 34.1% compared with… […]
  • Choosing the Right Rubber Material and Process for Your Medical Parts
    When it’s time to design and develop a new medical device that calls for an elastomer component, there are a number of material options and manufacturing processes to consider. The long list of material properties impacting performance includes your prospective polymer’s end-use environment, chemical compatibility, hardness, compression set, tensile properties and manufacturability — to name… […]
  • 3M’s healthcare segment registers growth in Street-beating Q2
    3M (NYSE:MMM) reported second-quarter results that beat the consensus forecast — with the company’s healthcare segment showing especially robust growth. The St. Paul, Minn.–based company posted profits of $1.5 billion, or $2.59 per share, on sales of $9 billion for the three months ended June 30, 2021, for a 16.7% bottom-line gain on sales growth of… […]
  • Evren Technologies earbud PTSD treatment device nabs FDA breakthrough device designation
    Evren Technologies this week announced that it received FDA breakthrough device designation for its Phoenix earbud device that treats PTSD. Gainesville, Fla.-based Evren Technologies designed the Phoenix device as a discreet earbud design that delivers transcutaneous auricular vagal nerve stimulation in a closed-loop system. It can be paired with the company’s PTSD symptom tracking app… […]
  • BD acquires resorbable polymer maker Tepha
    BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed amount. Franklin Lakes, N.J.–based BD said that it will use Lexington, Mass.–based Tepha’s resorbable polymer technology to accelerate growth of the company’s surgical mesh for soft tissue repair, reconstruction and regeneration. Tepha’s GalaFlex portfolio is also included in the acquisition.… […]
  • LifeSignals remote patient monitor wins FDA clearance
    LifeSignals today announced that it has received FDA 510(k) clearance for its LX1550 multi-parameter remote monitoring platform. Fremont, Calif.–based LifeSignals designed the LX1550 to continuously collect patient physiological data from home and in healthcare settings. The platform has a single-use wearable multi-parameter biosensor that records electrocardiography (ECG), heart rate, respiration rate, skin temperature and body… […]
  • Blackrock Neurotech and ClearPoint Neuro want to automate brain implant surgeries
    ClearPoint Neuro (NSDQ:CLPT) announced an agreement with Blackrock Neurotech to develop automated technologies for brain implant surgeries. The partnership will seek to develop an automated surgical solution for implanting brain-computer interfaces (BCIs) into patients with neurological disorders — including from paralysis, ALS, blindness and hearing loss. Solana Beach, Calif.–based ClearPoint Neuro said in a news… […]

Leave a Reply